Financhill
Back

Arbutus Biopharma Stock Predictions

Arbutus Biopharma Stock Forecast

  • Is Arbutus Biopharma Stock Undervalued?
    The current Arbutus Biopharma [ABUS] share price is $3.65. The Score for ABUS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Arbutus Biopharma Stock Go Up Next Year?

Data Unavailable

Arbutus Biopharma Stock Rating

Data Unavailable

Arbutus Biopharma Stock Price History

Is ABUS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arbutusbio.com

52-Week Data

52-Week High:
4.73
52-Week Low:
1.75

Prediction Charts

Market Cap:
691.64M
Price in USD:
3.65
Volume:
777.66K
Beta:
1.21

Technical Analysis

SMA50:
4.02
SMA100:
3.81
SMA200:
3.33
52-Wk Change:
106.21%

Stock Predictions

  • Is Arbutus Biopharma stock public?
    Yes, Arbutus Biopharma is a publicly traded company.
  • What is the Arbutus Biopharma stock quote today?
    The Arbutus Biopharma stock price is 3.65 USD today.
  • How to buy Arbutus Biopharma stock online?
    You can buy Arbutus Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-24 4.04 4.05 4.08 4.01
Oct-25 4.05 3.97 4.09 3.95
Oct-28 4.01 4.05 4.10 4.01
Oct-29 4.05 4.04 4.05 3.97
Oct-30 4.01 3.94 4.03 3.93
Oct-31 3.94 3.85 3.96 3.83
Nov-1 3.85 3.96 3.99 3.80
Nov-4 3.96 3.86 3.96 3.86
Nov-5 3.86 3.96 3.96 3.80
Nov-6 3.85 3.92 3.96 3.60
Nov-7 3.92 3.73 3.92 3.70
Nov-8 3.75 3.75 3.79 3.70
Nov-11 3.75 3.74 3.84 3.73
Nov-12 3.73 3.65 3.75 3.61

Arbutus Biopharma Earnings

Data Unavailable

Arbutus Biopharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.